跳至主要内容
临床试验/EUCTR2005-001669-33-GB
EUCTR2005-001669-33-GB进行中(未招募)1 期

ew therapeutic targets in stroke prevention: the effect of allopurinol on the cerebral vasculature of patients with subcortical stroke

Greater Glasgow NHS Health Board / University of Glasgow co-sponsorship0 个研究点目标入组 80 人开始时间: 2005年10月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Subcortical ischaemic stroke
  • 2. Index stroke between two weeks and three months prior to randomisation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. >70% extra-cranial internal carotid artery stenosis
  • 2. Known coronary arterial disease
  • 3. Significant co-morbidity
  • 4. Contra-indication to or indication for administration of allopurinol
  • 5. Contra-indication to administration of acetazolamide
  • 6. Concurrent azathioprine or 6-mercaptopurine therapy
  • 7. Serum creatinine concentration greater than 250 micromoles per litre

研究者

发起方
Greater Glasgow NHS Health Board / University of Glasgow co-sponsorship

相似试验

ew therapeutic targets in stroke prevention: the... | 临床试验